FIELD: biotechnology.
SUBSTANCE: described is an anticancer composition containing a tumor-specific oncolytic adenovirus and an immune response control point inhibitor. A recombinant adenovirus with inserted IL-12 and shVEGF or IL-12 and GM-CSF-RLX genes.
EFFECT: invention exhibits an excellent anti-cancer effect by enhancing immune functions, and has been confirmed, that such anticancer effect is markedly enhanced by simultaneous introduction of an immune response with an inhibitor of the control point, and thus the present invention can be used as a key technique in treating cancer.
10 cl, 1 ex, 23 dwg
Title |
Year |
Author |
Number |
ANTICANCER COMPOSITION CONTAINING TUMOR-SPECIFIC ONCOLYTIC ADENO VIRUS AND INHIBITOR OF CONTROL POINT OF IMMUNE RESPONSE |
2018 |
|
RU2777523C2 |
ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX |
2017 |
|
RU2742726C2 |
ANTI-TUMOUR COMPOSITION |
2019 |
|
RU2768287C1 |
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS |
2009 |
- Khemminki Akseli
- Kanerva Anna
- Cherullo Vinchentso
- Pesonen Sari
|
RU2520823C2 |
BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS |
2017 |
- Kezada, Serkhio
- Peggs, Karl
- Arse Vargas, Frederik
|
RU2759970C2 |
RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT |
2012 |
- Li, Sang Dzin
- Kim,Jun Khee,
- Kim,In Khoo
- Choi,Kiung Kho
- Chun,Kiung-Khee
|
RU2575620C2 |
CONSTRUCTED CELLS, EXPRESSING MULTIPLE IMMUNOMODULATORS, AND THEREOF APPLICATION |
2009 |
- Bich Robert Patterson
- Rid Tomas D.
|
RU2573912C2 |
ONCOLYTIC VIRUS FOR IMMUNOLOGIC CONTROL POINT MODULATORS EXPRESSION |
2015 |
- Silvestr Natali
- Gejst Mishel
- Rittner Karola
- Marshan Zhan-Batist
- Tiudelle Kristin
|
RU2696312C2 |
METHODS AND COMPOSITIONS FOR TUSC2-IMMUNOTHERAPY |
2017 |
|
RU2755903C2 |
COMBINATION THERAPY USING REIC/DKK-3 GENE AND IMMUNE RESPONSE CHECKPOINT INHIBITOR |
2017 |
- Kumon Hiromi
- Lowenthal Richard
|
RU2767997C2 |